Filing Details
- Accession Number:
- 0001209191-17-037923
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-06-05 18:06:18
- Reporting Period:
- 2017-06-01
- Filing Date:
- 2017-06-05
- Accepted Time:
- 2017-06-05 18:06:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1557290 | A Stuart Arbuckle | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp\Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-06-01 | 13,594 | $53.74 | 145,061 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-06-01 | 13,594 | $124.00 | 131,467 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2017-06-02 | 25,500 | $77.31 | 156,967 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-06-02 | 31,875 | $83.36 | 188,842 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-06-02 | 57,375 | $129.02 | 131,467 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-06-01 | 13,594 | $0.00 | 13,594 | $53.74 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-06-02 | 25,500 | $0.00 | 25,500 | $77.31 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-06-02 | 31,875 | $0.00 | 31,875 | $83.36 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2022-09-03 | No | 4 | M | Direct | |
| 12,750 | 2024-02-04 | No | 4 | M | Direct | |
| 2,125 | 2023-07-29 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 140 | Indirect | 401(k) |
Footnotes
- Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $124.00 (range $124.00 to $124.04).
- Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $129.02 (range $129.00 to $129.16).
- Fully vested.
- The option vests in 16 quarterly installments from 02/05/2014.
- The option vests in 16 quarterly installments from 07/30/2013.
Billionaire Hedge Funds
